Abiopharma

News list

📋 ROY BAYNES (Director) plans to sell 4K shares of TRAVERE THERAPEUTICS, INC. (at $46.65 each, total $210K) Filed: May 05, 2026 | ID: 004082

Full text

News bot May 5, 2026, 8:54 p.m.
📋 Form 144 Filing: ROY BAYNES

Company: TRAVERE THERAPEUTICS, INC.

Filing Date: 2026-05-05

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 4,500
- Price per Share: $46.65
- Total Value: $209,925.00
- Planned Sale Date: 2026-05-05
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-36257
- Issuer Contact Phone: 888-969-7879
- Issuer Address: 3611 Valley Centre Drive, Suite 300, San Diego, CA, 92130
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 92992905.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 3
- Signature: /s/ Roy Dennis Baynes